“Impact of the Third Molars in Oral Health-related Quality of Life”

Overview

The aim of this study is to evaluate the impact of the third molars in oral health-related quality of life, before and after surgical removal using a validated and frequently used in international investigations instrument (OHIP-14).

Full Title of Study: “”Impact of the Third Molars in Oral Health-related Quality of Life””

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 3, 2020

Detailed Description

This is a prospective study that evaluates the oral health-related quality of life through the application of the self-administered OHIP-14 before and after the surgical removal of third molars. The inclusion criteria were adults' patients older than 18 years, referred for oral surgery. Patients with chronic diseases and acute pericoronitis were excluded. The assessment was performed at three times: pre-surgical planning 1 day before surgery (T0), 10 days (T1) and 2 – 3 months after surgery (T2)

Interventions

  • Procedure: third molar surgical removal
    • ambulatory surgical intervention of the maxilla and / or mandible for third molar removal

Clinical Trial Outcome Measures

Primary Measures

  • changes in oral health related quality of life after orthognathic surgery assessed with Short form Oral Health Impact Profile (OHIP-14)
    • Time Frame: baseline to 10 days and 2 – 3 months after surgery
    • Short form Oral Health Impact Profile (OHIP-14) was applied at 3 times: baseline, one week before surgery (T1), 10 days after surgery (T2) and 2 – 3 months after surgery (T3). A paired t-test was used to assess the mean (SD) changes in patients undergoing orthognathic surgery. The magnitude of the change was evaluated calculating the standardized response mean (SRM). The Short Form Oral Health Impact Profile (OHIP-14) is an instrument for assessment oral health-related quality of life. 14 √≠tems values: min = 0 / max = 56 higher scores mean a worse outcome

Participating in This Clinical Trial

Inclusion Criteria

  • Adults patients over 18 years old Exclusion Criteria:

  • Patients with chronic diseases and acute pericoronitis

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Hospital Carlos Van Buren
  • Collaborator
    • Universidad de La Frontera
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Valentina Duarte, Principal Investigator, Hospital Carlos Van Buren

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.